ITGA2B and acute coronary syndrome: Indeed, the cyclooxygenase inhibitor, aspirin, ADP antagonists, ticlopidine and clopidogrel, and GPIIb/IIIa inhibitors, abciximab, tirofiban, and eptifibatide, are used clinically to reduce the risks of MI, stroke, and acute coronary syndrome [51].